Tag Archives: Patients

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »

Mobile app for pacemaker patients trims need for monitors

Medtronic is marketing a mobile app for patients with pacemakers that communicates with patients’ smartphones and tablet devices. The MyCareLink Heart app securely sends device data to the Medtronic CareLink network, which can eliminate the need for remote monitoring hardware, according to the vendor, which manufactures biomedical engineering devices and technology. “The mobile app is… Read More »